Marktprognose für Strahlenonkologie im asiatisch-pazifischen Raum bis 2031 – Regionale Analyse – nach Typ (externe Strahlentherapie und interne Strahlentherapie) und Anwendung (Brustkrebs, Prostatakrebs, Lungenkrebs, Kopf- und Halskrebs, Gebärmutterhalskrebs und andere)
Strategische Initiativen in der Strahlenonkologie kurbeln den Markt für Strahlenonkologie im asiatisch-pazifischen Raum an
Die Strahlenonkologie birgt ein enormes Potenzial in der Krebsbehandlung. Darüber hinaus wird erwartet, dass die ständige Weiterentwicklung der Strahlentherapie durch die Marktteilnehmer in Bezug auf Produktentwicklung, Innovation, Produkteinführung, Produktzulassung, Fusion, Übernahme und Partnerschaften usw. zum Marktwachstum beiträgt. Einige der jüngsten strategischen Initiativen auf dem Markt sind:
- Im Mai 2024 brachte Elekta seinen neuesten Linearbeschleuniger (Linac) Evo auf den Markt, einen CT-Linac mit neuer hochauflösender, durch KI verbesserter Bildgebung, der adaptive Strahlentherapie offline und online sowie verbesserte standardmäßige bildgeführte Strahlentherapiebehandlungen ermöglichen kann.
- Im Mai 2024 arbeitete The Icon Group mit Cyberknife Australia Pty Ltd zusammen, um bis zu sechs neue Strahlenonkologiekliniken einzurichten (geplantes Joint Venture), die Strahlenonkologiebehandlungen mit dem „Cyberknife“-System anbieten werden.
- Im Mai 2024 brachte GE HealthCare Revolution RT auf den Markt, eine neue Computertomographie (CT)-Lösung für die Strahlentherapie mit innovativen Hard- und Softwarelösungen zur Verbesserung der Bildgenauigkeit und Vereinfachung des Simulationsworkflows für einen individuelleren und nahtloseren onkologischen Behandlungsverlauf für Ärzte und Patienten.
- Im April 2024 präsentierte Accuray Incorporated auf der ESTRO 2024 Fortschritte bei Hard- und Software zur Verbesserung der Krebsbehandlung. Die CyberKnife- und Radixact-Plattformen der neuesten Generation bieten medizinischen Behandlungsteams die notwendige Technologie, um die Heilkraft der Strahlentherapie zu steigern und den Schwerpunkt des diesjährigen Kongresses umzusetzen, nämlich die Versorgungslücke zu schließen.
- Im September 2023 brachte MVision AI die erste umfassende leitlinienbasierte Segmentierungslösung (GBS) für eine effektive Konturierung der Strahlentherapie auf den Markt. Guide erleichtert klinischen Teams die genaue Bewertung KI-generierter Strukturen und ermöglicht ihnen so, ihre Konturierungsfähigkeiten zu verfeinern. Verify ermöglicht den visuellen und volumetrischen Vergleich von Konturen und erleichtert Kliniken das Erkennen von Ähnlichkeiten und Unterschieden. Die kombinierte Implementierung von Guide Verify und Contour+ deckt alle klinischen Anforderungen der Konturierung in der Strahlentherapie ab.
Daher gibt es unter den Marktteilnehmern auf dem Markt für Strahlenonkologie zunehmend strategische Initiativen, die das Marktwachstum verstärken und reichlich Gelegenheiten für den Markt für Strahlenonkologie schaffen dürften.
Überblick über den Markt für Strahlenonkologie im asiatisch-pazifischen Raum
Der Bereich der Strahlenonkologie hat sich in China aufgrund bedeutender technologischer Fortschritte schnell entwickelt. Joint Ventures haben eine entscheidende Rolle bei der Verbesserung der Zugänglichkeit von Strahlenonkologiesystemen gespielt. Mit diesen Initiativen konzentrieren sich die Unternehmen auch auf die Entwicklung hochtechnologischer Therapieprodukte. China Isotope and Radiation Corporation (CIRC) und Accuray, ein in den USA ansässiger Entwickler von Strahlentherapiesystemen, gründeten im Januar 2019 ein Joint Venture. Dieses Projekt nutzt Accurays hochmoderne Behandlungslösungen und lokale Fertigungskapazitäten, um den ungedeckten Bedarf auf dem chinesischen Markt zu decken. Solche Initiativen zeigen Chinas Engagement für die Entwicklung von Kompetenzen im Bereich der Strahlenonkologie im Land, was in den kommenden Jahren bemerkenswerte Aussichten für den Markt für Strahlenonkologie eröffnen würde.
Umsatz und Prognose des Marktes für Strahlenonkologie im asiatisch-pazifischen Raum bis 2031 (Mio. USD)
Segmentierung des Marktes für Strahlenonkologie im asiatisch-pazifischen Raum
Der Markt für Strahlenonkologie im asiatisch-pazifischen Raum ist nach Typen, Anwendung und Land unterteilt.
Basierend auf den Typen ist der Markt für Strahlenonkologie im asiatisch-pazifischen Raum in externe Strahlentherapie und interne Strahlentherapie unterteilt. Das Segment der externen Strahlentherapie hatte 2023 einen größeren Marktanteil.
In Bezug auf die Anwendung ist der Markt für Strahlenonkologie im asiatisch-pazifischen Raum in Brustkrebs, Prostatakrebs, Lungenkrebs, Kopf- und Halskrebs, Gebärmutterhalskrebs und andere unterteilt. Das Segment Brustkrebs hatte 2023 den größten Marktanteil.
Nach Ländern ist der Markt für Strahlenonkologie im asiatisch-pazifischen Raum in China, Japan, Indien, Australien, Südkorea und den Rest des asiatisch-pazifischen Raums segmentiert. China dominierte 2023 den Marktanteil der Strahlenonkologie im asiatisch-pazifischen Raum.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Panacea Medical Technologies Pvt. Ltd und Curium sind einige der führenden Unternehmen auf dem Markt der Strahlenonkologie im asiatisch-pazifischen Raum.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Asia Pacific Radiation Oncology Market - Key Market Dynamics
4.1 Market Drivers:
4.1.1 Increasing Prevalence of Cancer
4.1.2 Initiatives to Support Developments in Radiation Oncology
4.2 Market Restraints
4.2.1 High Cost of Radiotherapy Equipment
4.3 Market Opportunities
4.3.1 Strategic Initiatives in Radiation Oncology
4.4 Future Trends
4.4.1 Technological Advancement in Radiation Oncology
4.5 Impact of Drivers and Restraints:
5. Radiation Oncology Market - Asia Pacific Market Analysis
5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
6. Asia Pacific Radiation Oncology Market Analysis - by Types
6.1 External Beam Radiation Therapy
6.1.1 Overview
6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Internal Beam Radiation Therapy
6.2.1 Overview
6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7. Asia Pacific Radiation Oncology Market Analysis - by Application
7.1 Breast Cancer
7.1.1 Overview
7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Prostate Cancer
7.2.1 Overview
7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Lung Cancer
7.3.1 Overview
7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Head and Neck Cancer
7.4.1 Overview
7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Cervical Cancer
7.5.1 Overview
7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Radiation Oncology Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
8.1.1.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.1.1 China: Radiation Oncology Market Breakdown, by Types
8.1.1.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.1.4 China: Radiation Oncology Market Breakdown, by Application
8.1.1.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 Japan: Radiation Oncology Market Breakdown, by Types
8.1.1.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.2.4 Japan: Radiation Oncology Market Breakdown, by Application
8.1.1.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.3.1 India: Radiation Oncology Market Breakdown, by Types
8.1.1.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.3.4 India: Radiation Oncology Market Breakdown, by Application
8.1.1.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 Australia: Radiation Oncology Market Breakdown, by Types
8.1.1.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.4.4 Australia: Radiation Oncology Market Breakdown, by Application
8.1.1.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
8.1.1.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
8.1.1.6 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.6.1 Rest of APAC: Radiation Oncology Market Breakdown, by Types
8.1.1.6.2 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.6.3 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.6.4 Rest of APAC: Radiation Oncology Market Breakdown, by Application
9. Radiation Oncology Market - Industry Landscape
9.1 Overview
9.2 Growth Strategies in Radiation Oncology Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Varian Medical Systems Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview (Siemens Healthineers AG)
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Elekta AB
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Accuray Incorporated
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 IBA Worldwide (Ion Beam Applications SA)
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Becton Dickinson and Co
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Mevion Medical Systems
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 NTP RADIOISOTOPES
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Mallinckrodt Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Panacea Medical Technologies Pvt. Ltd
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Curium
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Radiation Oncology Market Segmentation
Table 2. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 15. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 16. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 17. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 19. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 20. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 21. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 22. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 24. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 25. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 28. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. Asia Pacific Radiation Oncology Market Segmentation, by Country
Figure 2. Radiation Oncology Market - Key Market Dynamics
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Asia Pacific Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 17. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 19. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Growth Strategies in Radiation Oncology Market
- Varian Medical Systems Inc.
- Elekta AB.
- Accuray Incorporated.
- IBA Worldwide (Ion Beam Applications SA).
- Becton Dickinson and Co.
- Mevion Medical Systems.
- NTP RADIOISOTOPES.
- Mallinckrodt Plc.
- Panacea Medical Technologies Pvt. Ltd
- Curium.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific radiation oncology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific radiation oncology market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.